Navales, Edelyn O.
HRN: 22-52-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2023
CEFUROXIME 1.5GM (VIAL)
02/27/2023
02/28/2023
IVT
1.5g
Q8 X 2 Doses
S/P LTCS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes